SlideShare una empresa de Scribd logo
1 de 23
Descargar para leer sin conexión
Signal Detection of
Adverse Medical Device
Events in the
FDA MAUDE Database
Eric Brinsfield, MS
Presenter & Research Collaborator

David Olaleye, MSCE, PhD
Author & Primary Research Statistician

SAS Institute Inc.
Cary, NC
                         Company Confidential - For Internal Use Only
                     Copyright © 2010, SAS Institute Inc. All rights reserved.
Disclosure Statement

 Both presenters are employees of SAS Institute
 We have no conflicts of interest



 Disclaimer

The views and opinions expressed in the following
PowerPoint slides are those of the individual presenters
and should not be attributed to ISPE or to SAS Institute.



                                                                                 2


                         Company Confidential - For Internal Use Only
                     Copyright © 2010, SAS Institute Inc. All rights reserved.
Study Objectives
Determine if text mining can be used to:
   Detect signals of adverse events in
    spontaneous reporting data
   Better understand or triage signals
    generated by traditional disproportionality
    methods

            Phase 1:
                Evaluate unsupervised text mining
                Using FDA MAUDE database
                Focused on stents
                                                                                     3


                         Company Confidential - For Internal Use Only
                                                                                 3
                     Copyright © 2010, SAS Institute Inc. All rights reserved.
Definitions
 Safety Signal
   “A report or reports of an event with an unknown
    causal relationship to treatment that is recognized as
    worthy of further exploration and continued surveillance.”
     » Council for International Organizations of Medical
       Sciences (CIOMS)
 “Recognition” is often the results of
   Analytical or automatic signal detection methods that look
    for unexpected patterns in data sources such as:
     » Spontaneously reported data
     » Observational healthcare data
     » Insurance claims data


                                                                                    4


                            Company Confidential - For Internal Use Only
                        Copyright © 2010, SAS Institute Inc. All rights reserved.
Methods

 Data Source = MAUDE
     FDA Spontaneous Reporting System Database for Med. Devices
      MAUDE - Manufacturer and User Facility Device Experience
     Contains the narrative entered by the reporter

 Target Devices
     endovascular graft system and coronary stent devices
     devices classified as a stent in the “product_category_code”:
      » MAF, MIH, NIN, NIO, NIP, NIM, and NIQ
      » http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPCD/classif
        ication.cfm?ID=896


                                                                                           5


                               Company Confidential - For Internal Use Only
                                                                                       5
                           Copyright © 2010, SAS Institute Inc. All rights reserved.
MAUDE (2001-2008)
Spontaneous “safety” reports on medical devices
Strengths:
   Only surveillance system which covers devices
    marketed in the entire US
   Largest number of case reports on adverse outcomes
    and malfunctions for medical devices
   Provides opportunity to detect signals of new, rare
    and unusual adverse clinical outcomes
    » Usually warrants further investigation
   Includes narrative description of events
    » Better than AERS which does not include narrative

                                                                                    6


                            Company Confidential - For Internal Use Only
                        Copyright © 2010, SAS Institute Inc. All rights reserved.
Characteristics of Spontaneous Report
 Suitable for hypotheses generation; not for confirmation or
  rates computation
 Exhibit under-reporting and other reporting biases; lack of
  control group, etc.
 Data quality, ascertainment, accuracy and completeness of
  information are usually poor
 Includes events and incidents not causally related to
  medical device exposure
 Does not distinguish between label versus off-label uses of
  approved products
 Contains minimal or no patient history and other potential
  causal factors
 Do not provide estimates of exposure (worse in drugs)                              7


                             Company Confidential - For Internal Use Only
                         Copyright © 2010, SAS Institute Inc. All rights reserved.
Study Design: Case-Series
                  Source Population
     All MAUDE reports received between 2006 – 2010
                      (N=35954)


Study Device Cohort                                           Study Events
MAUDE reports for stents                                      •       Death (D)
with product codes:                                           •       Injury (I)
   MAF, MIH, NIN, NIO,                                        •       Malfunctions (M)
   NIP, NIM, and NIQ                                          •       Other (O)


           Device-Adverse Outcomes Pairs
                       (N=28)
                                                                                         8


                          Company Confidential - For Internal Use Only
                      Copyright © 2010, SAS Institute Inc. All rights reserved.
Analysis Steps

1. Attempt analysis using text mining alone
     Ignore device
     Evaluate if general text mining provides any insights
2. Perform standard disproportionality analysis on
   structured data
     PRR, EBGM, Adj. Residual
3. Identify device-AE pairs that have:
     High scores
     Especially in the “Other” classification
4. Investigate the device with text mining
     Include all outcome classifications

                                                                                     9


                             Company Confidential - For Internal Use Only
                         Copyright © 2010, SAS Institute Inc. All rights reserved.
Text Mining Process

 Parse terms to create documents-terms frequency matrix
 Use singular value decomposition (SVD) to measure
  association and perform hierarchical clustering
 Use entropy method to cluster SVDs for documents
  classification




                                                                                 10


                         Company Confidential - For Internal Use Only
                     Copyright © 2010, SAS Institute Inc. All rights reserved.
Sample Narrative - Injury
Example of Manufacturer Report - Injury
 the product labeling for a p154 states that this product is indicated for
  use in pts with obstruction of major biliary ducts. the product labeling
  also states that the stent may be increased post-placement by
  expanding with a larger diameter balloon. the following was obtained
  through conversation with the user facility on 1/15/98. after deciding that
  a ptca procedure in a renal artery did not yield adequate results, the md
  attempted to place a medium biliary stent in the artery. the physician
  reported to co. that he had difficulty visualizing the stent and that it was
  difficult to place. he deployed the stent, but was not satisfied with the
  outcome. in response, he decided to place a second stent inside of the
  first. however, the stents interlocked and the physician decided to
  remove both stents, he was able to withdraw the stent up to sheath tip in
  the femoral artery, but needed a vascular surgeon to completely remove
  them. info regarding the type of removal procedure has not been
  provided to co. the physician further stated that he believes that the first
  stent had not fully opened. it was mounted on a meditech glidex balloon.


                                                                                             11


                                     Company Confidential - For Internal Use Only
                                 Copyright © 2010, SAS Institute Inc. All rights reserved.
Concept Linking and Exploration




                                                                           12


                   Company Confidential - For Internal Use Only
               Copyright © 2010, SAS Institute Inc. All rights reserved.
Text mining clusters over all reports




                                                                            13


                    Company Confidential - For Internal Use Only
                Copyright © 2010, SAS Institute Inc. All rights reserved.
Text Mining Over All Reports

 Results are interesting
 But inconclusive
 Lose track of the device
 But may detect new trends for all stent devices in study


Cannot really do comparisons due to lack of denominator.
(Same problems as always with spontaneous reports.)


Next, run disproportionality to narrow the focus…

                                                                                   14


                           Company Confidential - For Internal Use Only
                       Copyright © 2010, SAS Institute Inc. All rights reserved.
Disproportionality Results for
   Carotid Stent (NIM)

                                                                                          Adjusted        MGPS
Adverse Event                                        Freq                                 Residual      (EBGM)
Death                                                       276                                   0.8    0.86728

Injury                                                  2043                                      1.1   1.130264

Malfuntion                                                  271                                   0.4   0.424803

Other                                                           24                                1.6   3.648191

 * Adjusted Residual:   Flagged at values over 1.5
   EBGM:                Flagged at values over 2.0


                                                                                                                   15


                                          Company Confidential - For Internal Use Only
                                      Copyright © 2010, SAS Institute Inc. All rights reserved.
Target for Text Mining Evaluation

 NIM showed high proportion of “Other”
    Based on relative percentage of reports
    Based on signal scoring algorithms
    All methods suggested a flag
    Although only 24 cases, the method could show promise
 Run text mining against all NIM reports
    Include all outcomes to fully understand reports
    Look for possible explanations or hypotheses




                                                                                    16


                            Company Confidential - For Internal Use Only
                        Copyright © 2010, SAS Institute Inc. All rights reserved.
N
Text Mining Clusters for NIM
+percutaneous +unk dissection performance +unstable repaired                                376
+malfunction 'device remains implanted'
reactions collapsing +'premature deployment' cracks +'product quality                           41
issue' replaced performance collapsed
malfunction fractures +fracture +'inaccurate delivery' fractured                            846
malfunctions drift +'premature deployment'
+normal dissection +unk 'no information' +na collapsing unk fractured                           69
'device issue' broke 'no known device problem' +break broken +'shaft                        227
break' reaction reactions
abnormal +fracture +continuous +bent cracks unk +break fractured                                65
filter +na 'difficult to advance' breaks reaction +bent +malfunction                        150
replaced
'device remains implanted' collapsed 'no flow' performance +crack                               44
+break +collapse filter
fractured repair +crack breaks +collapse +'product quality issue' 'no                           31
flow' reaction                                                                                       17


                                    Company Confidential - For Internal Use Only
                                Copyright © 2010, SAS Institute Inc. All rights reserved.
18


    Company Confidential - For Internal Use Only
Copyright © 2010, SAS Institute Inc. All rights reserved.
Manual Review of Text for “Other”

 Most were not adverse events that persisted
 Some seemed like “FYI” reports.
 Two included notification of a formal study
 Most patients still had the stent in place (assumed)
 Some cases of installation problems:
    Potential installer error
    Most did not involve an adverse event




                                                                                      19


                              Company Confidential - For Internal Use Only
                          Copyright © 2010, SAS Institute Inc. All rights reserved.
Conclusion

 Text mining shows promise for recognizing
  primary words and patterns
 Hard to form hypotheses from bulk text mining on
  spontaneous database
 Combination with disproportionality analysis
  creates signals that can be further analyzed with
  text mining
 Terms in the “Other” category overlap with other
  categories

                                                                                    20


                       Company Confidential - For Internal Use Only
                                                                               20
                   Copyright © 2010, SAS Institute Inc. All rights reserved.
Next Steps

Need further analysis that includes:
 Large target group for further triage
    “Other” was too small in this case
 Preferred term matching and encoding
    To clean up fuzziness and reduce clusters
 Content categorization
    Look for more structure and combine with ontologies
 Sentiment analysis
    Determine if overall sentiment was good or bad



                                                                                         21


                            Company Confidential - For Internal Use Only
                                                                                    21
                        Copyright © 2010, SAS Institute Inc. All rights reserved.
Final Thoughts
“What the future portends is more and more
information — Everests of it. There won’t be
anything we won’t know. But there will be no
one thinking about it.”
   From:
   New York Times - August 13, 2011
   The Elusive Big Idea
   By NEAL GABLER

   Neal Gabler is a senior fellow at the Annenberg Norman Lear Center at the University of
   Southern California and the author of “Walt Disney: The Triumph of the American Imagination.”




We need to help make time for thinking.
                                                                                                   22


                                       Company Confidential - For Internal Use Only
                                   Copyright © 2010, SAS Institute Inc. All rights reserved.
Thank You
Contacts:

 Eric Brinsfield  eric.brinsfield@sas.com

 David Olaleye  david.olaleye@sas.com




                       Company Confidential - For Internal Use Only
                   Copyright © 2010, SAS Institute Inc. All rights reserved.

Más contenido relacionado

Destacado

Evaluation of as media
Evaluation of as mediaEvaluation of as media
Evaluation of as mediajlimbmedia
 
Izispot diapo
Izispot diapoIzispot diapo
Izispot diapoxrank
 
Evaluation – Bryn Hughes
Evaluation – Bryn HughesEvaluation – Bryn Hughes
Evaluation – Bryn HughesBryn Hughes
 
Electro-Thermal and Semiconductivity Behaviour of Natural Sintered Complex Ca...
Electro-Thermal and Semiconductivity Behaviour of Natural Sintered Complex Ca...Electro-Thermal and Semiconductivity Behaviour of Natural Sintered Complex Ca...
Electro-Thermal and Semiconductivity Behaviour of Natural Sintered Complex Ca...Al Baha University
 
חינוך טכנולוגי
חינוך טכנולוגיחינוך טכנולוגי
חינוך טכנולוגיDganit Hartman
 
ARC 404/504 Presentation
ARC 404/504 PresentationARC 404/504 Presentation
ARC 404/504 PresentationLeon Ge
 

Destacado (13)

Evaluation of as media
Evaluation of as mediaEvaluation of as media
Evaluation of as media
 
Unit 4
Unit 4Unit 4
Unit 4
 
Speech
Speech Speech
Speech
 
Izispot diapo
Izispot diapoIzispot diapo
Izispot diapo
 
Evaluation – Bryn Hughes
Evaluation – Bryn HughesEvaluation – Bryn Hughes
Evaluation – Bryn Hughes
 
Electro-Thermal and Semiconductivity Behaviour of Natural Sintered Complex Ca...
Electro-Thermal and Semiconductivity Behaviour of Natural Sintered Complex Ca...Electro-Thermal and Semiconductivity Behaviour of Natural Sintered Complex Ca...
Electro-Thermal and Semiconductivity Behaviour of Natural Sintered Complex Ca...
 
חינוך טכנולוגי
חינוך טכנולוגיחינוך טכנולוגי
חינוך טכנולוגי
 
Ozel egitim-video
Ozel egitim-videoOzel egitim-video
Ozel egitim-video
 
Brochure SVT English
Brochure SVT EnglishBrochure SVT English
Brochure SVT English
 
Ins
InsIns
Ins
 
2014 451782
2014 4517822014 451782
2014 451782
 
ARC 404/504 Presentation
ARC 404/504 PresentationARC 404/504 Presentation
ARC 404/504 Presentation
 
Ozel pilot-okulu
Ozel pilot-okuluOzel pilot-okulu
Ozel pilot-okulu
 

Similar a Text Mining the MAUDE Database

Signal Detection With Oracle Products by Dipti Kadam, DBMS Consulting
Signal Detection With Oracle Products by Dipti Kadam, DBMS ConsultingSignal Detection With Oracle Products by Dipti Kadam, DBMS Consulting
Signal Detection With Oracle Products by Dipti Kadam, DBMS ConsultingUntil ROI
 
Digital Processes with PowerPath Barcodes, Scanning and Digital Imaging
Digital Processes with PowerPath Barcodes, Scanning and Digital ImagingDigital Processes with PowerPath Barcodes, Scanning and Digital Imaging
Digital Processes with PowerPath Barcodes, Scanning and Digital ImagingChris Godin✪
 
Sequence analysis in the regulated domain - A Pistoia Alliance Debates webina...
Sequence analysis in the regulated domain - A Pistoia Alliance Debates webina...Sequence analysis in the regulated domain - A Pistoia Alliance Debates webina...
Sequence analysis in the regulated domain - A Pistoia Alliance Debates webina...Pistoia Alliance
 
SAS Big Data Forum - Transforming Big Data into Corporate Gold
SAS Big Data Forum - Transforming Big Data into Corporate GoldSAS Big Data Forum - Transforming Big Data into Corporate Gold
SAS Big Data Forum - Transforming Big Data into Corporate GoldLouis Fernandes
 
Stephen Friend Dana Farber Cancer Institute 2011-10-24
Stephen Friend Dana Farber Cancer Institute 2011-10-24Stephen Friend Dana Farber Cancer Institute 2011-10-24
Stephen Friend Dana Farber Cancer Institute 2011-10-24Sage Base
 
Challenges and-opportunities-in-software-driven-medical-sciences
Challenges and-opportunities-in-software-driven-medical-sciencesChallenges and-opportunities-in-software-driven-medical-sciences
Challenges and-opportunities-in-software-driven-medical-sciencesPEPGRA Healthcare
 
Safety gauge presentation
Safety gauge presentationSafety gauge presentation
Safety gauge presentationomrishafran
 
Multiplex Assays in Translational Medicine: Technologies, Applications, and F...
Multiplex Assays in Translational Medicine: Technologies, Applications, and F...Multiplex Assays in Translational Medicine: Technologies, Applications, and F...
Multiplex Assays in Translational Medicine: Technologies, Applications, and F...ReportLinker.com
 
SAS an open ecosystem for Artifical Intelligence - Dean Zouari
SAS an open ecosystem for Artifical Intelligence - Dean ZouariSAS an open ecosystem for Artifical Intelligence - Dean Zouari
SAS an open ecosystem for Artifical Intelligence - Dean ZouariInstitute of Contemporary Sciences
 
An OGMS-based Model for Clinical Information
An OGMS-based Model for Clinical InformationAn OGMS-based Model for Clinical Information
An OGMS-based Model for Clinical Informationoberkampf
 
Infinity Success Conference Hit
Infinity Success Conference HitInfinity Success Conference Hit
Infinity Success Conference HitShane Molinari
 
Adequate directions for use "In the Age of AI and Watson"
Adequate directions for use "In the Age of AI and Watson"Adequate directions for use "In the Age of AI and Watson"
Adequate directions for use "In the Age of AI and Watson"Stephen Allan Weitzman
 
Practical Guide - www.devicematters.com
Practical Guide - www.devicematters.comPractical Guide - www.devicematters.com
Practical Guide - www.devicematters.comPowerViz
 

Similar a Text Mining the MAUDE Database (20)

Signal Detection With Oracle Products by Dipti Kadam, DBMS Consulting
Signal Detection With Oracle Products by Dipti Kadam, DBMS ConsultingSignal Detection With Oracle Products by Dipti Kadam, DBMS Consulting
Signal Detection With Oracle Products by Dipti Kadam, DBMS Consulting
 
Digital Processes with PowerPath Barcodes, Scanning and Digital Imaging
Digital Processes with PowerPath Barcodes, Scanning and Digital ImagingDigital Processes with PowerPath Barcodes, Scanning and Digital Imaging
Digital Processes with PowerPath Barcodes, Scanning and Digital Imaging
 
Sequence analysis in the regulated domain - A Pistoia Alliance Debates webina...
Sequence analysis in the regulated domain - A Pistoia Alliance Debates webina...Sequence analysis in the regulated domain - A Pistoia Alliance Debates webina...
Sequence analysis in the regulated domain - A Pistoia Alliance Debates webina...
 
SAS Big Data Forum - Transforming Big Data into Corporate Gold
SAS Big Data Forum - Transforming Big Data into Corporate GoldSAS Big Data Forum - Transforming Big Data into Corporate Gold
SAS Big Data Forum - Transforming Big Data into Corporate Gold
 
Stephen Friend Dana Farber Cancer Institute 2011-10-24
Stephen Friend Dana Farber Cancer Institute 2011-10-24Stephen Friend Dana Farber Cancer Institute 2011-10-24
Stephen Friend Dana Farber Cancer Institute 2011-10-24
 
Standards-based Solution for National Level Document Sharing.
Standards-based Solution for National Level Document Sharing.Standards-based Solution for National Level Document Sharing.
Standards-based Solution for National Level Document Sharing.
 
Challenges and-opportunities-in-software-driven-medical-sciences
Challenges and-opportunities-in-software-driven-medical-sciencesChallenges and-opportunities-in-software-driven-medical-sciences
Challenges and-opportunities-in-software-driven-medical-sciences
 
Dr. Ying Xiao: Radiation Therapy Oncology Group Bioinformatics
Dr. Ying Xiao: Radiation Therapy Oncology Group BioinformaticsDr. Ying Xiao: Radiation Therapy Oncology Group Bioinformatics
Dr. Ying Xiao: Radiation Therapy Oncology Group Bioinformatics
 
Safety gauge presentation
Safety gauge presentationSafety gauge presentation
Safety gauge presentation
 
Simplifying Surgery
Simplifying SurgerySimplifying Surgery
Simplifying Surgery
 
Platform Adoption
Platform AdoptionPlatform Adoption
Platform Adoption
 
Multiplex Assays in Translational Medicine: Technologies, Applications, and F...
Multiplex Assays in Translational Medicine: Technologies, Applications, and F...Multiplex Assays in Translational Medicine: Technologies, Applications, and F...
Multiplex Assays in Translational Medicine: Technologies, Applications, and F...
 
SAS an open ecosystem for Artifical Intelligence - Dean Zouari
SAS an open ecosystem for Artifical Intelligence - Dean ZouariSAS an open ecosystem for Artifical Intelligence - Dean Zouari
SAS an open ecosystem for Artifical Intelligence - Dean Zouari
 
MED dra Coding -MSSO
MED dra Coding -MSSOMED dra Coding -MSSO
MED dra Coding -MSSO
 
An OGMS-based Model for Clinical Information
An OGMS-based Model for Clinical InformationAn OGMS-based Model for Clinical Information
An OGMS-based Model for Clinical Information
 
Power your IT infrastructure with Analytics
Power your IT infrastructure with AnalyticsPower your IT infrastructure with Analytics
Power your IT infrastructure with Analytics
 
SLAS Informatics SIG: SLAS2013 Presentation
SLAS Informatics SIG: SLAS2013 PresentationSLAS Informatics SIG: SLAS2013 Presentation
SLAS Informatics SIG: SLAS2013 Presentation
 
Infinity Success Conference Hit
Infinity Success Conference HitInfinity Success Conference Hit
Infinity Success Conference Hit
 
Adequate directions for use "In the Age of AI and Watson"
Adequate directions for use "In the Age of AI and Watson"Adequate directions for use "In the Age of AI and Watson"
Adequate directions for use "In the Age of AI and Watson"
 
Practical Guide - www.devicematters.com
Practical Guide - www.devicematters.comPractical Guide - www.devicematters.com
Practical Guide - www.devicematters.com
 

Text Mining the MAUDE Database

  • 1. Signal Detection of Adverse Medical Device Events in the FDA MAUDE Database Eric Brinsfield, MS Presenter & Research Collaborator David Olaleye, MSCE, PhD Author & Primary Research Statistician SAS Institute Inc. Cary, NC Company Confidential - For Internal Use Only Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 2. Disclosure Statement  Both presenters are employees of SAS Institute  We have no conflicts of interest Disclaimer The views and opinions expressed in the following PowerPoint slides are those of the individual presenters and should not be attributed to ISPE or to SAS Institute. 2 Company Confidential - For Internal Use Only Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 3. Study Objectives Determine if text mining can be used to:  Detect signals of adverse events in spontaneous reporting data  Better understand or triage signals generated by traditional disproportionality methods Phase 1:  Evaluate unsupervised text mining  Using FDA MAUDE database  Focused on stents 3 Company Confidential - For Internal Use Only 3 Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 4. Definitions  Safety Signal  “A report or reports of an event with an unknown causal relationship to treatment that is recognized as worthy of further exploration and continued surveillance.” » Council for International Organizations of Medical Sciences (CIOMS)  “Recognition” is often the results of  Analytical or automatic signal detection methods that look for unexpected patterns in data sources such as: » Spontaneously reported data » Observational healthcare data » Insurance claims data 4 Company Confidential - For Internal Use Only Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 5. Methods  Data Source = MAUDE  FDA Spontaneous Reporting System Database for Med. Devices MAUDE - Manufacturer and User Facility Device Experience  Contains the narrative entered by the reporter  Target Devices  endovascular graft system and coronary stent devices  devices classified as a stent in the “product_category_code”: » MAF, MIH, NIN, NIO, NIP, NIM, and NIQ » http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPCD/classif ication.cfm?ID=896 5 Company Confidential - For Internal Use Only 5 Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 6. MAUDE (2001-2008) Spontaneous “safety” reports on medical devices Strengths:  Only surveillance system which covers devices marketed in the entire US  Largest number of case reports on adverse outcomes and malfunctions for medical devices  Provides opportunity to detect signals of new, rare and unusual adverse clinical outcomes » Usually warrants further investigation  Includes narrative description of events » Better than AERS which does not include narrative 6 Company Confidential - For Internal Use Only Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 7. Characteristics of Spontaneous Report  Suitable for hypotheses generation; not for confirmation or rates computation  Exhibit under-reporting and other reporting biases; lack of control group, etc.  Data quality, ascertainment, accuracy and completeness of information are usually poor  Includes events and incidents not causally related to medical device exposure  Does not distinguish between label versus off-label uses of approved products  Contains minimal or no patient history and other potential causal factors  Do not provide estimates of exposure (worse in drugs) 7 Company Confidential - For Internal Use Only Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 8. Study Design: Case-Series Source Population All MAUDE reports received between 2006 – 2010 (N=35954) Study Device Cohort Study Events MAUDE reports for stents • Death (D) with product codes: • Injury (I) MAF, MIH, NIN, NIO, • Malfunctions (M) NIP, NIM, and NIQ • Other (O) Device-Adverse Outcomes Pairs (N=28) 8 Company Confidential - For Internal Use Only Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 9. Analysis Steps 1. Attempt analysis using text mining alone  Ignore device  Evaluate if general text mining provides any insights 2. Perform standard disproportionality analysis on structured data  PRR, EBGM, Adj. Residual 3. Identify device-AE pairs that have:  High scores  Especially in the “Other” classification 4. Investigate the device with text mining  Include all outcome classifications 9 Company Confidential - For Internal Use Only Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 10. Text Mining Process  Parse terms to create documents-terms frequency matrix  Use singular value decomposition (SVD) to measure association and perform hierarchical clustering  Use entropy method to cluster SVDs for documents classification 10 Company Confidential - For Internal Use Only Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 11. Sample Narrative - Injury Example of Manufacturer Report - Injury  the product labeling for a p154 states that this product is indicated for use in pts with obstruction of major biliary ducts. the product labeling also states that the stent may be increased post-placement by expanding with a larger diameter balloon. the following was obtained through conversation with the user facility on 1/15/98. after deciding that a ptca procedure in a renal artery did not yield adequate results, the md attempted to place a medium biliary stent in the artery. the physician reported to co. that he had difficulty visualizing the stent and that it was difficult to place. he deployed the stent, but was not satisfied with the outcome. in response, he decided to place a second stent inside of the first. however, the stents interlocked and the physician decided to remove both stents, he was able to withdraw the stent up to sheath tip in the femoral artery, but needed a vascular surgeon to completely remove them. info regarding the type of removal procedure has not been provided to co. the physician further stated that he believes that the first stent had not fully opened. it was mounted on a meditech glidex balloon. 11 Company Confidential - For Internal Use Only Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 12. Concept Linking and Exploration 12 Company Confidential - For Internal Use Only Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 13. Text mining clusters over all reports 13 Company Confidential - For Internal Use Only Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 14. Text Mining Over All Reports  Results are interesting  But inconclusive  Lose track of the device  But may detect new trends for all stent devices in study Cannot really do comparisons due to lack of denominator. (Same problems as always with spontaneous reports.) Next, run disproportionality to narrow the focus… 14 Company Confidential - For Internal Use Only Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 15. Disproportionality Results for Carotid Stent (NIM) Adjusted MGPS Adverse Event Freq Residual (EBGM) Death 276 0.8 0.86728 Injury 2043 1.1 1.130264 Malfuntion 271 0.4 0.424803 Other 24 1.6 3.648191 * Adjusted Residual: Flagged at values over 1.5 EBGM: Flagged at values over 2.0 15 Company Confidential - For Internal Use Only Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 16. Target for Text Mining Evaluation  NIM showed high proportion of “Other”  Based on relative percentage of reports  Based on signal scoring algorithms  All methods suggested a flag  Although only 24 cases, the method could show promise  Run text mining against all NIM reports  Include all outcomes to fully understand reports  Look for possible explanations or hypotheses 16 Company Confidential - For Internal Use Only Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 17. N Text Mining Clusters for NIM +percutaneous +unk dissection performance +unstable repaired 376 +malfunction 'device remains implanted' reactions collapsing +'premature deployment' cracks +'product quality 41 issue' replaced performance collapsed malfunction fractures +fracture +'inaccurate delivery' fractured 846 malfunctions drift +'premature deployment' +normal dissection +unk 'no information' +na collapsing unk fractured 69 'device issue' broke 'no known device problem' +break broken +'shaft 227 break' reaction reactions abnormal +fracture +continuous +bent cracks unk +break fractured 65 filter +na 'difficult to advance' breaks reaction +bent +malfunction 150 replaced 'device remains implanted' collapsed 'no flow' performance +crack 44 +break +collapse filter fractured repair +crack breaks +collapse +'product quality issue' 'no 31 flow' reaction 17 Company Confidential - For Internal Use Only Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 18. 18 Company Confidential - For Internal Use Only Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 19. Manual Review of Text for “Other”  Most were not adverse events that persisted  Some seemed like “FYI” reports.  Two included notification of a formal study  Most patients still had the stent in place (assumed)  Some cases of installation problems:  Potential installer error  Most did not involve an adverse event 19 Company Confidential - For Internal Use Only Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 20. Conclusion  Text mining shows promise for recognizing primary words and patterns  Hard to form hypotheses from bulk text mining on spontaneous database  Combination with disproportionality analysis creates signals that can be further analyzed with text mining  Terms in the “Other” category overlap with other categories 20 Company Confidential - For Internal Use Only 20 Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 21. Next Steps Need further analysis that includes:  Large target group for further triage  “Other” was too small in this case  Preferred term matching and encoding  To clean up fuzziness and reduce clusters  Content categorization  Look for more structure and combine with ontologies  Sentiment analysis  Determine if overall sentiment was good or bad 21 Company Confidential - For Internal Use Only 21 Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 22. Final Thoughts “What the future portends is more and more information — Everests of it. There won’t be anything we won’t know. But there will be no one thinking about it.” From: New York Times - August 13, 2011 The Elusive Big Idea By NEAL GABLER Neal Gabler is a senior fellow at the Annenberg Norman Lear Center at the University of Southern California and the author of “Walt Disney: The Triumph of the American Imagination.” We need to help make time for thinking. 22 Company Confidential - For Internal Use Only Copyright © 2010, SAS Institute Inc. All rights reserved.
  • 23. Thank You Contacts: Eric Brinsfield  eric.brinsfield@sas.com David Olaleye  david.olaleye@sas.com Company Confidential - For Internal Use Only Copyright © 2010, SAS Institute Inc. All rights reserved.